The impact of clinical pharmacy services in China on the quality use of medicines: a systematic review in context of China’s current healthcare reform
Open Access
- 19 September 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in Health Policy and Planning
- Vol. 29 (7), 849-872
- https://doi.org/10.1093/heapol/czt067
Abstract
Introduction Recently, China initiated an ambitious healthcare reform aiming to provide affordable and equitable basic health care to all by 2020. To meet these goals, new policies issued by China’s Ministry of Health mandate clinical pharmacy services be integrated into China’s hospitals. This review aims to highlight the impact of clinical pharmacy services on the quality use of medicines in hospitals in China. Methods Both English and Chinese databases were used. For the English databases, Web of Science, Medline, International Pharmaceutical Abstracts and Embase were searched using the following keywords (‘pharmacists’ OR ‘pharmacy’ OR ‘pharmaceutical services/pharmaceutical care’) AND (‘China’). For the Chinese database, Chinese Biomedical Literature Database on disc was searched using the following keywords (‘clinical pharmacist’ OR ‘clinical pharmacy’ OR ‘pharmaceutical care’ OR ‘pharmaceutical services’). Articles were then retrieved from WanFang database and China Knowledge Resource Integrated Database. Results A total of 75 published papers were included in this review. The majority of studies were conducted in the inpatient setting (68%), which included clinical pharmacy interventions such as educating doctors and patients, evaluating and monitoring the implementation of hospital policies and/or reviewing medications on the ward. In the outpatient setting, the majority of studies conducted involved educating patients. Clinical pharmacy services frequently focused on antimicrobials (44%). More than half of these studies employed an administrative intervention alongside the clinical pharmacy service. Conclusion Clinical pharmacy services in China, with its unique healthcare system and cultural nuances, appear to positively influence patient care and the appropriate use of medications. From the published literature, it is expected that clinical pharmacy services can make a strong contribution to China’s healthcare reform with further governmental and educational support.This publication has 40 references indexed in Scilit:
- China progresses with health reform but challenges remainThe Lancet, 2011
- Chinese doctors are under threatThe Lancet, 2010
- Evaluation and justification of clinical pharmacy servicesExpert Review of Pharmacoeconomics & Outcomes Research, 2009
- The Definition of Clinical PharmacyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008
- 2006 National Clinical Pharmacy Services Survey: Clinical Pharmacy Services, Collaborative Drug Management, Medication Errors, and Pharmacy TechnologyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008
- Clinical Pharmacy Services, Pharmacy Staffing, and Hospital Mortality RatesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Clinical Pharmacy Services, Pharmacy Staffing, and Adverse Drug Reactions in United States HospitalsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006
- Pharmacist‐Provided Anticoagulation Management in United States Hospitals: Death Rates, Length of Stay, Medicare Charges, Bleeding Complications, and TransfusionsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004
- The state of the world's pharmacy: a portrait of the pharmacy professionJournal of Interprofessional Care, 2002
- Clinical Pharmacy Services, Pharmacy Staffing, and the Total Cost of Care in United States HospitalsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000